相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Genetic landscape of recurrent ASXL1, U2AF1, SF3B1, SRSF2, and EZH2 mutations in 304 Chinese patients with myelodysplastic syndromes
Lingyun Wu et al.
TUMOR BIOLOGY (2016)
Mutations of myelodysplastic syndromes (MDS): An update
Bani Bandana Ganguly et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2016)
Mutation in TET2 or TP53 predicts poor survival in patients with myelodysplastic syndrome receiving hypomethylating treatment or stem cell transplantation
M. Kim et al.
BONE MARROW TRANSPLANTATION (2015)
SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition
Eunhee Kim et al.
CANCER CELL (2015)
High-throughput mutational screening adds clinically important information in myelodysplastic syndromes and secondary or therapy-related acute myeloid leukemia
Mohsen Karimi et al.
HAEMATOLOGICA (2015)
High-throughput mutational screening adds clinically important information in myelodysplastic syndromes and secondary or therapy-related acute myeloid leukemia
Mohsen Karimi et al.
HAEMATOLOGICA (2015)
Clinical and biological implications of driver mutations in myelodysplastic syndromes
Elli Papaemmanuil et al.
BLOOD (2013)
Test-Firing Ammunition for Spliceosome Inhibition in Cancer
Scott M. Dehm
CLINICAL CANCER RESEARCH (2013)
Spliceosome mutations exhibit specific associations with epigenetic modifiers and proto-oncogenes mutated in myelodysplastic syndrome
Syed A. Mian et al.
HAEMATOLOGICA (2013)
Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia
Raphael Itzykson et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Clonal diversity of recurrently mutated genes in myelodysplastic syndromes
M. J. Walter et al.
LEUKEMIA (2013)
Mutations affecting mRNAsplicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes
Frederik Damm et al.
BLOOD (2012)
Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes
Felicitas Thol et al.
BLOOD (2012)
The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution
Shang-Ju Wu et al.
BLOOD (2012)
Revised International Prognostic Scoring System for Myelodysplastic Syndromes
Peter L. Greenberg et al.
BLOOD (2012)
Defects in spliceosomal machinery: a new pathway of leukaemogenesis
Jaroslaw P. Maciejewski et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Validation of a Prognostic Model and the Impact of Mutations in Patients With Lower-Risk Myelodysplastic Syndromes
Rafael Bejar et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
The spliceosome: a flexible, reversible macromolecular machine
Aaron A. Hoskins et al.
TRENDS IN BIOCHEMICAL SCIENCES (2012)
Frequent pathway mutations of splicing machinery in myelodysplasia
Kenichi Yoshida et al.
NATURE (2011)
Splicing regulator SC35 is essential for genomic stability and cell proliferation during mammalian organogenesis
Ran Xiao et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
分享论文
